QSS
AXNX icon

Quantitative Systematic Strategies’s Axonics, Inc. Common Stock AXNX Stock Holding History

Quantitative Systematic Strategies’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,166
Closed -$369K – 690
2021
Q1 		$369K Sell
6,166
-4,044
-40% -$220K 0.06% 431
2020
Q4 		$510K Sell
10,210
-2,158
-17% -$101K 0.07% 385
2020
Q3 		$631K Sell
12,368
-9,100
-42% -$380K 0.11% 276
2020
Q2 		$754K Buy
+21,468
New +$739K 0.15% 228
2019
Q1 		– Sell
-10,814
Closed -$163K – 683
2018
Q4 		$163K Buy
+10,814
New +$161K 0.04% 556

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Quantitative Systematic Strategies's AXNX Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2021, closing a stake of 6,166 shares — an estimated $369K sold.

Quantitative Systematic Strategies first reported a position in AXNX in Q4 2018 and held it in 5 quarters. The position peaked at $754K in Q2 2020. 177 funds tracked by Wall St. Rank hold AXNX as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining Axonics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 6,166 Axonics, Inc. Common Stock shares in Q2 2021, an estimated $369K.
  • Quantitative Systematic Strategies first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Axonics, Inc. Common Stock position peaked at $754K in Q2 2020.
  • 177 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.